SelectScience InterviewsDrug Discovery & Development

Next-generation mass spectrometry for metabolomics and biotherapeutics

28 Jul 2025
Next-generation mass spectrometry for metabolomics and biotherapeutics

Dr. James Langridge from Water Corporation introduces the Xevo™ MRT Mass Spectrometer. Discover how this state of the art QTof system, specially designed for challenging applications in metabolomics, lipidomics and biotherapeutics, offers a highly accurate resolution to tackle key industry concerns around performance and speed.

This video was filmed at ASMS 2025, Baltimore, USA.

Other videos from Waters

Links

Tags